Physician profile
Norman Kane
NPI 1588625982
$343,836.57
in general payments reported to CMS, 2019-2025
19 companies · $821 in 2025
The $821 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $116 · 2021: $342K · 2023: $231 · 2024: $184 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668 · Education: $569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.78 |
| Education | $568.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $342,238.96 | 2021 | |
| Stryker Corporation | $806.49 | 2019-2025 | Accolade, Triathlon, Gamma |
| Depuy Synthes Sales INC. | $272.29 | 2023-2025 | Orthovisc |
| Bioventus LLC | $110.46 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Illuminoss Medical, INC. | $105.23 | 2023-2024 | Photodynamic Bone Stabilization Procedure Pack |
| Arthrosurface Incorporated | $51.60 | 2019 | |
| Bsn Medical INC | $38.83 | 2025 | |
| Heron Therapeutics, INC. | $24.83 | 2021 | |
| Heraeus Medical, LLC. | $23.02 | 2020 | |
| Pacira Therapeutics, INC. | $22.72 | 2019 | |
| Nevro Corp. | $22.10 | 2024 | Senza |
| Fidia Pharma USA INC. | $19.95 | 2025 | Triluron, Hymovis |
| Ermi LLC | $19.14 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.90 | 2019 | |
| Ethicon US, LLC | $16.95 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $15.56 | 2025 | |
| Acell, INC. | $15.33 | 2019 | |
| Wright Medical Technology, INC. | $14.21 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$85,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norman Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.